Opinion|Videos|June 24, 2024
Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient
Author(s)Iltefat Hamzavi, MD
A dermatologist provides clinical insights on differential diagnosis strategies when considering hidradenitis suppurativa in patients and the challenges associated with diagnosis.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What is in your differential diagnosis when considering hidradenitis suppurativa (HS) in a patient and how is this disease definitively diagnosed?
- Average delay in HS diagnosis has been found to be around 10 years. What do you think accounts for this and why is it imperative for patients with HS to be diagnosed sooner?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
